Sidney F. Gomes
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Retraction Notice to "New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19" [Multiple Sclerosis and Related Disorders 57 (2022) 103321].
Journal: Multiple sclerosis and related disorders
Published: January 10, 2025
New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19.
Journal: Multiple sclerosis and related disorders
Published: August 07, 2021
Coronavirus disease 2019 in Latin American patients with multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: June 28, 2021
Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system.
Journal: Arquivos de neuro-psiquiatria
Published: April 24, 2021
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: September 02, 2020
Severe Exacerbation of Multiple Sclerosis Following Withdrawal of Fingolimod.
Journal: Clinical drug investigation
Published: June 02, 2019
Late Onset of Neuromyelitis Optica Spectrum Disorders.
Journal: Neurology and therapy
Published: April 25, 2019
Clinical Characteristics of Patients With Neuromyelitis Optica Spectrum Disorders With Early Onset.
Journal: Journal of child neurology
Published: April 24, 2019
Migraine in 746 patients with multiple sclerosis.
Journal: Arquivos de neuro-psiquiatria
Published: March 17, 2019
Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD).
Journal: Multiple sclerosis and related disorders
Published: September 15, 2018
High levels of alexithymia in patients with multiple sclerosis.
Journal: Dementia & neuropsychologia
Published: July 11, 2018
Seroconversion of JCV antibodies is strongly associated to natalizumab therapy.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: June 21, 2018
Last Updated: 09/26/2026